NZ502144A - Multi-subtype FIV vaccines - Google Patents

Multi-subtype FIV vaccines

Info

Publication number
NZ502144A
NZ502144A NZ502144A NZ50214496A NZ502144A NZ 502144 A NZ502144 A NZ 502144A NZ 502144 A NZ502144 A NZ 502144A NZ 50214496 A NZ50214496 A NZ 50214496A NZ 502144 A NZ502144 A NZ 502144A
Authority
NZ
New Zealand
Prior art keywords
fiv
immune response
subtype fiv
fiv vaccines
response against
Prior art date
Application number
NZ502144A
Other languages
English (en)
Inventor
Janet K Yamamoto
Original Assignee
Univ California
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Univ Florida filed Critical Univ California
Priority to NZ513388A priority Critical patent/NZ513388A/en
Publication of NZ502144A publication Critical patent/NZ502144A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
NZ502144A 1995-08-25 1996-08-23 Multi-subtype FIV vaccines NZ502144A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ513388A NZ513388A (en) 1995-08-25 1996-08-23 Treatment using multi-subtype FIV vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51938695A 1995-08-25 1995-08-25

Publications (1)

Publication Number Publication Date
NZ502144A true NZ502144A (en) 2001-09-28

Family

ID=24068097

Family Applications (3)

Application Number Title Priority Date Filing Date
NZ513388A NZ513388A (en) 1995-08-25 1996-08-23 Treatment using multi-subtype FIV vaccines
NZ316347A NZ316347A (en) 1995-08-25 1996-08-23 Multi-subtype fiv vaccines
NZ502144A NZ502144A (en) 1995-08-25 1996-08-23 Multi-subtype FIV vaccines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NZ513388A NZ513388A (en) 1995-08-25 1996-08-23 Treatment using multi-subtype FIV vaccines
NZ316347A NZ316347A (en) 1995-08-25 1996-08-23 Multi-subtype fiv vaccines

Country Status (17)

Country Link
US (5) US5846825A (de)
EP (2) EP0848615B1 (de)
JP (4) JP4142741B2 (de)
KR (2) KR100482616B1 (de)
AT (2) ATE335809T1 (de)
AU (3) AU728750B2 (de)
BR (1) BR9610343A (de)
CA (1) CA2230029C (de)
DE (3) DE69634820T2 (de)
DK (2) DK1090985T3 (de)
ES (2) ES2269042T3 (de)
HK (1) HK1038584A1 (de)
IL (3) IL163873A0 (de)
NZ (3) NZ513388A (de)
PL (2) PL188041B1 (de)
PT (2) PT1090985E (de)
WO (1) WO1997007817A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0848615B1 (de) 1995-08-25 2005-06-08 University of Florida Research Foundation, Inc. Impfstoff gegen mehrere fiv-subtypen
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6458528B1 (en) * 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
US20030091987A1 (en) 2001-02-22 2003-05-15 Yamamoto Janet K. Materials and methods for detecting, preventing, and treating retroviral infection
NZ529326A (en) 2001-05-10 2006-09-29 Wyeth Corp Composition and method for increasing cell density in cell cultures infected with lentivirus
EP1622644A2 (de) 2003-05-12 2006-02-08 University Of Florida Research Foundation, Inc. Materialien und verfahren zur impfung gegen fiv infektionen
US7658927B2 (en) * 2003-05-12 2010-02-09 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
AU2005267607B8 (en) 2003-09-11 2009-07-16 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
ATE435425T1 (de) 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
WO2005062053A2 (en) 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2556141A1 (en) 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2576930C (en) 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
EP1761564A1 (de) * 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US8394581B2 (en) 2007-07-25 2013-03-12 The Kitasato Institute Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
US8596026B2 (en) * 2010-08-05 2013-12-03 Kraft Foods Group Brands Llc Vacuum flow wrap packaging system and method of packaging

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
US6107077A (en) * 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
CA1341439C (en) * 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
WO1992000098A1 (en) * 1990-06-29 1992-01-09 Daniel Zagury Methods of inducing immune response to aids virus
WO1993001278A1 (en) * 1991-07-05 1993-01-21 The Regents Of The University Of California Feline lymphoid cell lines capable of producing fiv
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
WO1994020622A1 (en) * 1993-03-11 1994-09-15 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
IT1276509B1 (it) * 1995-03-31 1997-10-31 Istituto Superiore Della Sanit Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
US6254872B1 (en) * 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
EP0848615B1 (de) * 1995-08-25 2005-06-08 University of Florida Research Foundation, Inc. Impfstoff gegen mehrere fiv-subtypen

Also Published As

Publication number Publication date
US6447993B1 (en) 2002-09-10
JP2007284442A (ja) 2007-11-01
AU2004203358B2 (en) 2007-10-25
NZ513388A (en) 2006-02-24
DE69636440T2 (de) 2006-12-21
CA2230029A1 (en) 1997-03-06
EP1090985A1 (de) 2001-04-11
DE69634820T2 (de) 2006-03-23
DE69636440D1 (de) 2006-09-21
KR100482616B1 (ko) 2005-09-02
EP0848615B1 (de) 2005-06-08
IL163873A0 (en) 2005-12-18
DK1090985T3 (da) 2006-12-04
AU772353B2 (en) 2004-04-22
ES2269042T3 (es) 2007-04-01
PT1090985E (pt) 2006-12-29
JP4142741B2 (ja) 2008-09-03
AU2004203358A1 (en) 2004-08-19
DK0848615T3 (da) 2005-10-03
DE69634820D1 (de) 2005-07-14
US7311921B2 (en) 2007-12-25
PT848615E (pt) 2005-10-31
KR20040047812A (ko) 2004-06-05
KR19990044093A (ko) 1999-06-25
IL123264A (en) 2006-09-05
PL188041B1 (pl) 2004-11-30
ATE335809T1 (de) 2006-09-15
US5846825A (en) 1998-12-08
JP5339687B2 (ja) 2013-11-13
JP2013079286A (ja) 2013-05-02
JPH11513031A (ja) 1999-11-09
ES2242967T3 (es) 2005-11-16
AU1972501A (en) 2001-05-03
US6605282B2 (en) 2003-08-12
PL325376A1 (en) 1998-07-20
EP0848615A1 (de) 1998-06-24
US20020172941A1 (en) 2002-11-21
US20080145381A1 (en) 2008-06-19
NZ316347A (en) 2000-02-28
KR100502568B1 (ko) 2005-07-20
BR9610343A (pt) 1999-12-21
JP4413132B2 (ja) 2010-02-10
AU6855596A (en) 1997-03-19
HK1038584A1 (en) 2002-03-22
PL186706B1 (pl) 2004-02-27
DE69636440T4 (de) 2007-09-27
CA2230029C (en) 2012-03-27
ATE297218T1 (de) 2005-06-15
AU728750B2 (en) 2001-01-18
JP2005261426A (ja) 2005-09-29
IL123264A0 (en) 1998-09-24
WO1997007817A1 (en) 1997-03-06
EP1090985B1 (de) 2006-08-09
US20040067242A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
NZ502144A (en) Multi-subtype FIV vaccines
DE3787663D1 (de) Impfstofformulierung.
BR9608615A (pt) Vacinas de vírus sincicial respiratório de ácido nucléico
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
NZ319377A (en) polypeptides comprising a portion of a soluble M tuberculosis antigen
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
WO1993001210A3 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
DE3650011D1 (de) EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
NZ213303A (en) Plasmodium protein, dna sequence and vaccine
DE69301733D1 (de) Impfstoffe gegen Metazoen-Parasiten
OA09037A (en) Prevention and treatement of retroviral disease.
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
ATE374622T1 (de) Genetische impstoffe mit adjuvans
NZ334582A (en) Polyprotein construct of a papillomavirus
BG63183B1 (bg) Анти-идиотипна ваксина срещу заболявания в резултат от патогенни отговори на специфични т-клетъчни популации

Legal Events

Date Code Title Description
PSEA Patent sealed
ASS Change of ownership

Owner name: REGENTS OF THE UNIVERSITY OF CALIFORNIA, US

Free format text: OLD OWNER(S): REGENTS OF THE UNIVERSITY OF CALIFORNIA; UNIVERSITY OF FLORIDA

Owner name: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, US

Free format text: OLD OWNER(S): REGENTS OF THE UNIVERSITY OF CALIFORNIA; UNIVERSITY OF FLORIDA

RENW Renewal (renewal fees accepted)
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: BY WAY OF DISCLAIMER

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired